MedPath

Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis

Conditions
Spontaneous Bacterial Peritonitis
Interventions
Other: serum amyloid A level
Registration Number
NCT02759497
Lead Sponsor
Tanta University
Brief Summary

One of the most common and serious complications in decompensated cirrhotic patients (DCPs) is bacterial infection.The most common infections in DCPs are cases of spontaneous bacterial peritonitis (SBP), which account for 40% 70% of cases, followed by urinary tract infections, pneumonia and cellulitis.

Serum amyloid A (SAA) and C-reactive protein (CRP) are acute-phase proteins predominantly produced and secreted by hepatocytes. Other cells including lymphocytes, monocytes, and macrophages can also produce these proteins. The induction of SAA and CRP synthesis is triggered by a number of cytokines, chiefly IL-6, which is released from a variety of cell types, but mainly from macrophages and monocytes at inflammatory sites

Detailed Description

Increased serum CRP and SAA levels have been found in a number of disorders, including bacterial infections, malignancies tissue injuries and tissue rejection. Therefore, new studies of early diagnosis, prevention and treatment are needed to improve clinical outcomes.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • • Decompansated cirrhosis with ascites, defined by a combination of any of the following:

    • Laboratory findings
    • Endoscopic results
    • Ultrasound
    • Histology
Exclusion Criteria
  • Creatinine>1.5 mg/dl
  • Other infection e.grespiratory,UTI ,gastrointestinal and skin infection.
  • Hepatocellular carcinoma
  • Other extrahepatic malignancy e.g ; chest
  • Any significant psychiatric illness or other medical comorbidity.
  • Any degenerative diseases.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Serum amyloid A level in SBPserum amyloid A levelserum amyloid A level
Serum amyloid A level in cirrhosisserum amyloid A levelSerum amyloid A level
Primary Outcome Measures
NameTimeMethod
Number of patients with elevated serum amyloid A6months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sherief Abd-Elsalam

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath